Wedbush Securities’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-45,369
| Closed | -$245K | – | 1011 |
|
2020
Q3 | $245K | Buy |
45,369
+3,852
| +9% | +$20.8K | 0.02% | 703 |
|
2020
Q2 | $217K | Buy |
41,517
+1,425
| +4% | +$7.45K | 0.02% | 744 |
|
2020
Q1 | $126K | Buy |
40,092
+4,046
| +11% | +$12.7K | 0.02% | 757 |
|
2019
Q4 | $145K | Sell |
36,046
-413
| -1% | -$1.66K | 0.01% | 901 |
|
2019
Q3 | $158K | Sell |
36,459
-8,818
| -19% | -$38.2K | 0.02% | 859 |
|
2019
Q2 | $181K | Sell |
45,277
-31,053
| -41% | -$124K | 0.02% | 846 |
|
2019
Q1 | $409K | Sell |
76,330
-9,161
| -11% | -$49.1K | 0.04% | 483 |
|
2018
Q4 | $439K | Sell |
85,491
-13,443
| -14% | -$69K | 0.06% | 399 |
|
2018
Q3 | $960K | Buy |
98,934
+72,884
| +280% | +$707K | 0.11% | 214 |
|
2018
Q2 | $266K | Buy |
26,050
+15,000
| +136% | +$153K | 0.03% | 600 |
|
2018
Q1 | $144K | Buy |
+11,050
| New | +$144K | 0.02% | 728 |
|